Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Recruiting
N/A
Interventional Study
Cervical Cancer
Cervical Cancer Screening
HPV DNA
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 25 – 49
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 1,980 (estimated)
- Sponsor
- Kenyatta National Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. C…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- Women ages 25-49 years
Exclusion Criteria:
* Pregnant women
* Women ≤6 weeks postpartum
* Women already confirmed to have cervical cancer
Contacts